Perhaps most notably for many patients, GLP-1 receptor agonists act on appetite centers in the brain, promoting satiety and reducing food intake
Pancreatic cancer: a review of current treatment and novel therapies
No diabetic retinopathy at baseline: typically annual exams, with earlier follow-up if high baseline A1c, large early A1c drop, or new symptoms Mild nonproliferative diabetic retinopathy: every six to twelve months, shorter intervals if rapid glucose changes or symptoms appear Moderate nonproliferative retinopathy: every three to six months Severe nonproliferative retinopathy: every two to three months Proliferative diabetic retinopathy or prior macular edema: individualized schedule, often every two to four months when stable, more frequent when starting treatment Starting semaglutide may justify scheduling one additional exam during the first six months in higher-risk patients to catch any early worsening
Some people worry these services are less legitimate than in-person care , but that's a misconception
Kondegowda NG, Fenutria R, Pollack IR, Orthofer M, Garcia-Ocaa A, Penninger JM, et al